Literature DB >> 1319066

Viricidal effect of stimulated human mononuclear phagocytes on human immunodeficiency virus type 1.

M J Chase1, S J Klebanoff.   

Abstract

Human monocytes stimulated with phorbol 12-myristate 13-acetate or opsonized zymosan in vitro were viricidal to human immunodeficiency virus type 1 (HIV-1) as measured by the inability of the virus to replicate in CEM cells. Monocytes, when stimulated, release myeloperoxidase (MPO) and produce H2O2; MPO reacts with H2O2 and chloride to form hypochlorous acid, a known microbicidal agent. The viricidal activity of stimulated monocytes was inhibited by the peroxidase inhibitor azide, implicating MPO, and by catalase but not heated catalase or superoxide dismutase, implicating H2O2. Stimulated monocytes from patients with chronic granulomatous disease (CGD) or hereditary MPO deficiency were not viricidal to HIV-1 unless they were supplemented with the H2O2-generating enzyme glucose oxidase or MPO, respectively. The viricidal activity of stimulated, glucose oxidase-supplemented CGD monocytes and MPO-supplemented MPO-deficient monocytes, like that of normal stimulated monocytes, was inhibited by azide and catalase. Monocytesmaintained in culture differentiate into macrophages with loss of MPO and decreased H2O2 production. The viricidal activity of 3- to 9-day monocyte-derived macrophages was decreased unless MPO was added, whereas the loss of viricidal activity by 12-day-old monocyte-derived macrophages was not reversed by MPO unless the cells were pretreated with gamma-interferon. These findings suggest that stimulated monocytes can be viricidal to HIV-1 through the release of the MPO/H2O2/chloride system and that the decreased viricidal activity on differentiation to macrophages results initially from the loss of MPO and, with more prolonged culture, also from a decreased respiratory burst that can be overcome by gamma-interferon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319066      PMCID: PMC49336          DOI: 10.1073/pnas.89.12.5582

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

3.  Infection of monocyte/macrophages by human T lymphotropic virus type III.

Authors:  D D Ho; T R Rota; M S Hirsch
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Antimicrobial activity of myeloperoxidase.

Authors:  S J Klebanoff; A M Waltersdorph; H Rosen
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus.

Authors:  F Kazazi; J M Mathijs; P Foley; A L Cunningham
Journal:  J Gen Virol       Date:  1989-10       Impact factor: 3.891

6.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

7.  Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.

Authors:  L Montagnier; J Gruest; S Chamaret; C Dauguet; C Axler; D Guétard; M T Nugeyre; F Barré-Sinoussi; J C Chermann; J B Brunet
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system.

Authors:  S J Klebanoff; R W Coombs
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission.

Authors:  S J Klebanoff; R W Coombs
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

View more
  10 in total

1.  Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity.

Authors:  Yin Liu; Yuval Ramot; Antonio Torrelo; Amy S Paller; Nuo Si; Sofia Babay; Peter W Kim; Afzal Sheikh; Chyi-Chia Richard Lee; Yongqing Chen; Angel Vera; Xue Zhang; Raphaela Goldbach-Mansky; Abraham Zlotogorski
Journal:  Arthritis Rheum       Date:  2012-03

2.  Neutralization of X4- and R5-tropic HIV-1 NL4-3 variants by HOCl-modified serum albumins.

Authors:  Svenja Polzer; Melanie van Yperen; Martin Kirst; Birco Schwalbe; Heiner Schaal; Michael Schreiber
Journal:  BMC Res Notes       Date:  2010-06-02

3.  Inactivation of human immunodeficiency virus type 1 by the amine oxidase-peroxidase system.

Authors:  S J Klebanoff; F Kazazi
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

4.  Virucidal effects of glucose oxidase and peroxidase or their protein conjugates on human immunodeficiency virus type 1.

Authors:  Y Yamaguchi; M Semmel; L Stanislawski; A D Strosberg; M Stanislawski
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

5.  Virucidal effect of myeloperoxidase on human immunodeficiency virus type 1-infected T cells.

Authors:  J Chochola; Y Yamaguchi; N Moguilevsky; A Bollen; A D Strosberg; M Stanislawski
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 6.  The effects of neutrophil-generated hypochlorous acid and other hypohalous acids on host and pathogens.

Authors:  Agnes Ulfig; Lars I Leichert
Journal:  Cell Mol Life Sci       Date:  2020-07-13       Impact factor: 9.261

Review 7.  Oxidative Stress in the Protection and Injury of the Lacrimal Gland and the Ocular Surface: are There Perspectives for Therapeutics?

Authors:  Camila Nunes Lemos; Lilian Eslaine Costa Mendes da Silva; Jacqueline Ferreira Faustino; Marina Zilio Fantucci; Adriana de Andrade Batista Murashima; Leidiane Adriano; Monica Alves; Eduardo Melani Rocha
Journal:  Front Cell Dev Biol       Date:  2022-03-11

8.  Neutrophils Turn Plasma Proteins into Weapons against HIV-1.

Authors:  Cornelia Speth; Martin F Brodde; Magdalena Hagleitner; Günter Rambach; Hugo Van Aken; Manfred Dierich; Beate E Kehrel
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

Review 9.  Biochemical and pathological studies on peroxidases -an updated review.

Authors:  Amjad A Khan; Arshad H Rahmani; Yousef H Aldebasi; Salah M Aly
Journal:  Glob J Health Sci       Date:  2014-05-13

Review 10.  Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.

Authors:  Qing-Bin Lu
Journal:  Cells       Date:  2020-06-13       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.